Medifast (MED) Misses Q4 EPS by 8c, Guidance Mixed
Get Alerts MED Hot Sheet
Price: $32.42 -0.15%
EPS Growth %: -59.1%
Financial Fact:
Selling, general, and administration: 43.21M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -59.1%
Financial Fact:
Selling, general, and administration: 43.21M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $0.38, $0.08 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $62.3 million versus the consensus estimate of $69.4 million.
Medifast sees FY2015 EPS of $1.85-$1.95, versus the consensus of $1.83. Medifast sees FY2015 revenue of $285-300 million, versus the consensus of $307.77 million.
Medifast sees Q1 2015 EPS of $0.33-$0.35, versus the consensus of $0.43. Medifast sees Q1 2015 revenue of $70-73 million, versus the consensus of $83.70 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- Vail Resorts (MTN) Reports Certain Ski Season Metrics for the Season-to-Date Period Ended April 14
- Benchmark on Take-Two's (TTWO) GTV 6 Release: 'we anticipate that the game will not be released within the fiscal year and expect it to launch in fiscal 2026 instead'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!